Companies
-
How a PBAC ‘yes’ has become the new ‘no’
- Mon Sep 7
New analysis reveals positive PBAC decisions are rising, but workable listings aren’t signalling a PBAC ‘yes’ is no longer what it used to be.
Read more -
Second nominee confirmed for MA Board
- Mon Sep 7
Another company leader confirms they will contest this year’s annual Board election with a number of eligible candidates still undecided.
Read more -
Look who’s returned to Medicines Australia
- Wed Sep 2
They left Medicines Australia, but as the association moves to negotiate a new strategic agreement with the government, is now back in the team.
Read more -
Roche Australia unveils flash new CBD digs
- Wed Sep 2
Ten years after Roche left its sprawling premises in Dee Why for Barangaroo, it is moving again – although this time, it’s not going nearly as far.
Read more -
Nine more companies sign MFN deals
- Wed Sep 2
CSL has joined eight other companies from Japan, India, the US and Europe in signing new deals with the US, taking the total number of companies to 26.
Read more -
Takeda adds firepower to patient advocacy
- Mon Aug 31
Public Affairs boss Paula Dry has picked a familiar face to lead patient advocacy in Takeda’s growing Oceania Public Affairs team.
Read more -
First targeted lupus treatment fast-tracked to PBS
- Mon Aug 31
PBS funds the first targeted treatment for lupus‑related kidney disease after the PBAC offered Roche a fast-tracked pricing pathway.
Read more -
Sanofi Global Vaccines Head in Sydney
- Mon Aug 31
Dr Jean‑François Toussaint will participate as an expert coach at the Australian Vaccine and Value Chain Conference held in Sydney this week.
Read more